SIRONA BIOCHEM WKN: A0RM6R ISIN: CA82967M1005 Kürzel: ZSB Forum: Aktien Thema: Hauptdiskussion

Die Katze ist aus dem Sack. Ich bin gespannt wie es weiter geht. Homepage läuft auch wieder

War doch abzusehen

es ist wahr!! oO

🙏

ich glaube es nicht ... ihr verar..sch.t mich? oder ?`

Muhaaa 🥲

https://www.sironabiochem.com

Lambo ist bestellt…

Yacht Kataloge werden wieder ausgekrammt

Das heist?

👍

We are pleased to announce we have entered into a global exclusive licensing agreement with Allergan Aesthetics, an AbbVie company (NYSE: ABBV)! ceo.ca/@nasdaq/sirona… It took longer, but all the more significant is this deal! #skincare #biotech #BREAKING $ABBV $SBM.V

Und es ist ... Allergan, wer hätte das gedacht ;-)

https://ceo.ca/@nasdaq/sirona-biochem-announces-exclusive-global-licensing

Vancouver, British Columbia – June 13, 2022 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce it has entered into a global exclusive licensing agreement with Allergan Aesthetics, an AbbVie company (NYSE: ABBV), pursuant to which Allergan Aesthetics will develop and commercialize topical skin care treatments based on active ingredients derived from certain of Sirona’s patents for TFC-1067 and related family of compounds. “We are very pleased to have finalized terms with a global leader in medical aesthetics and the innovator behind SkinMedicaTM, a leader in the science of skin rejuvenation”, said Dr. Howard Verrico, CEO of Sirona Biochem. “Our most recent clinical trial of TFC-1067 was a collaborative effort with Allergan Aesthetics to demonstrate the clinical potential in topical skin care treatments. This further validates our platform technology as viable for additional commercial products which we are actively pursuing. We would like to thank Dr. Linda Pullan of Pullan Consulting who assisted with our current success.” “Allergan Aesthetics’ global presence in the aesthetic space and goal to further enhance aesthetic medicine combined with Sirona’s disruptive technology made this all possible”, reports Dr. Linda Pullan, of Pullan Consulting. Under the license agreement, Sirona will a receive an upfront payment and further payments on achievement of milestones and royalties on product sales and has also agreed to financial terms as a supplier of its compounds.

Das mit dem "glauben" ist eine Sache für sich. Kann man, muss aber nicht.